Personalis to Present First NeXT Personal Data From Breast Cancer Study at ESMO 2026

PUBT · 1d ago
Personalis to Present First NeXT Personal Data From Breast Cancer Study at ESMO 2026
  • Personalis will present NeXT Personal blood-based cancer test data at ESMO 2026, October 23-27 in Madrid.
  • C-POST Phase 3 findings will cover updated overall survival and circulating tumor DNA analyses in high-risk cutaneous squamous cell carcinoma.
  • Initial B-STRONGER-1 findings will assess residual disease detection during preoperative treatment for early-stage triple-negative breast cancer.
  • Poster findings indicate tumor DNA changes predict early immunotherapy response and complement imaging assessments in advanced cancer.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Personalis Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610210600BIZWIRE_USPR_____20261019_BW479647) on October 21, 2026, and is solely responsible for the information contained therein.